MedPath
FDA Approval

ORPHENADRINE CITRATE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
STAT Rx USA LLC
DUNS: 786036330
Effective Date
May 1, 2012
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Orphenadrine(100 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

PSS World Medical Inc.

101822682

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

STAT Rx USA LLC

STAT Rx USA LLC

PSS World Medical Inc.

786036330

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ORPHENADRINE CITRATE

Product Details

NDC Product Code
42549-559
Application Number
ANDA040368
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
May 1, 2012
Code: X0A40N8I4SClass: ACTIBQuantity: 100 mg in 1 1
ETHYLCELLULOSESInactive
Code: 7Z8S9VYZ4BClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
© Copyright 2025. All Rights Reserved by MedPath